Krystal Biotech (KRYS) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 94.6%
EBITDA Margin: 47.4%
Op. Margin: 46.1%
Net Margin: 48.1%

Op. margin of 46.1% is up 5.1% YoY — cost efficiency is improving. Net margin at 48.1% and gross margin of 94.6% — earnings take a bigger bite when COGS stays lean..

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit